Key find could prevent deadly prostate cancer
Steve Connor
Steve Connor is the Science Editor of The Independent. He has won many awards for his journalism, including five-times winner of the prestigious British science writers’ award; the David Perlman Award of the American Geophysical Union; twice commended as specialist journalist of the year in the UK Press Awards; UK health journalist of the year and a special merit award of the European School of Oncology for his investigative journalism. He has a degree in zoology from the University of Oxford and has a special interest in genetics and medical science, human evolution and origins, climate change and the environment.
Tuesday 16 August 2011
Related articles
A blood test that can distinguish between the benign and dangerous forms of prostate cancer could soon be developed following a breakthrough in understanding the complex genetics behind the most common type of cancer in men.
Scientists believe they have identified a key difference between a "metastatic" prostate tumour that spreads to other parts of the body and a slow-growing tumour that does not. The finding could lead to a test for dangerous metastatic prostate cancer as well as new drugs that could prevent such tumours from spreading.
About 250,000 men in Britain live with prostate cancer but only a tiny fraction of these tumours will turn metastatic, which usually leads to death. One man in Britain dies of prostate cancer every hour, whereas 100 men per day will have the disease diagnosed.
Being able to distinguish between relatively benign, slow-growing tumours and aggressive cancers that are more likely to spread to other organs is one of the research priorities of cancer-funding organisations. Now a research team at the Cold Spring Harbor Laboratory in New York believes it may have found a vital clue that could lead to such a test.
"The ideal scenario is to be able to detect what we are looking for by taking blood samples, although that may prove to be too late. It might be better to pick up metastatic tumours by taking small biopsies from the prostate gland," said Professor Lloyd Trotman, who led the research team.
The study, published in the journal Cancer Cell, describes the relationship between three genes that all play a role in determining whether a prostate cell becomes cancerous and whether the resulting tumour is likely to spread.
The scientists found that a gene called PHLPP1 works in concert with another gene known as PTEN, which is mutated in about half of all prostate cancer sufferers. Normally both genes act as "tumour suppressors", which mean they prevent cancers from developing, but when they are both mutated, the result can lead to cancer.
A third gene, known a p53, also acts as a tumour suppressor and works like a "water sprinkler" when the two other genes are damaged to prevent the cancer "fire" from spreading further. However, when p53 is also mutated, a metastatic cancer is likely to develop, Professor Trotman said.
"This discovery led us to ask whether there are specific rules for prostate cancers to become lethal," he said. "In terms of diagnostic tests, having lost the three genes is a hallmark feature of many metastatic cancers. We could envisage a test that looks at the activity levels of these genes and whether they are en route to metastatic disease," he added.
It also opens the way to using drugs known to influence the metabolic pathways of these genes, which would have the effect of overriding damaged genes that would normally suppress tumours, Professor Trotman said.
-
Gay couple beaten in park urge MPs to moderate language on gay marriage
-
Strewth mate. Aussies wave goodbye to Britain as it becomes too pricey to stay
-
World news in pictures
-
X marks the spot: The find that could rewrite Australian history
-
Oklahoma tornado latest: At least 91 dead, including 20 children, as massive storm rips through Oklahoma City suburbs, flattening homes, shops, hospitals and schools
- 1 'He was lucky he didn't die' - George Michael fell out of speeding car onto M1 motorway, according to eye witness
- 2 Tottenham to smash pay scale with £150,000-a-week contract in attempt to tie Gareth Bale to club
- 3 Austerity has hardened the nation's heart
- 4 Gay couple beaten in park urge MPs to moderate language on gay marriage
- 5 Why Arsène Wenger must spend to put icing on the cake and buy likes of Stevan Jovetic for Arsenal
Get your summer started with British Military Fitness
BMF is the UK’s biggest and best loved outdoor fitness classes
Visit York
Find out what The Independent's resident travel expert has to say about one of the most beautiful small cities in the world
Enter the latest Independent competitions
Win anything from gadgets to five-star holidays on our competitions and offers page.
Business videos from commercial thought leaders
Watch the best in the business world give their insights into the world of business.
Independent Dating
iJobs General
Experienced Day Nursery Manager
£18000 - £22000 per annum: Randstad Education Leicester: Please request a copy...
Change Manager,Hampshire,Telecomms,SC Clear,£200PD
Negotiable: Orgtel: Change Manager, Hampshire, Telecomms, SC Cleared, £200 per...
Primary Teacher with Autism experience in Southwark
£120 - £160 per day + negotiable depending on experience: Randstad Education L...
Operations Analyst
£180 - £230 per day: Orgtel: Operations Analyst - Leading Bank in the City of ...
Day In a Page
The price of pacifism
Jason Isaacs: Groupies, theatre bores and James Bond
Sealand: 'Micronation' or illegal fortress?
Legend of James Hunt has set Hollywood hearts racing
Macklemore: 'I don't have moderation'







Comments